ResMed, Inc. (RMD) Tops Q3 EPS by 3c
ResMed, Inc. (NY
SE: RMD) reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
SE: RMD) reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.